Argan CEO sells 19,310 shares after RSU vesting
ARGAN INC President and CEO David Hibbert Watson reported multiple equity award vestings and one stock sale.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
ARGAN INC President and CEO David Hibbert Watson reported multiple equity award vestings and one stock sale. On April 17, 2026, he sold 19,310 shares of common stock in the open market at an average price of $602.11 per share, and held 49,998 shares directly afterward. Around the same time, several restricted stock unit awards vested, including time-based RSUs and performance-based RSUs. Footnotes state that 20,000 shares became issuable from earnings-per-share performance-based RSUs versus a 10,000-share target, and 10,000 shares became issuable from performance-based RSUs versus a 5,000-share target, indicating awards paid out above target levels.
Insider Trade Summary
Exercise and sale activity reported; no spread calculated
Exercise and Sale
11 txns
Insider
Watson David Hibbert
Role
PRESIDENT AND CEO
Sold
19,310 shs ($11.63M)
Approx. gross sale proceeds
$11.63M
Approx. exercise cost
$0.00
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Time-Based Restricted Stock Units | 4,000 | $0.00 | $0.00 |
| Exercise | Earnings Per Share Performance-Based Restricted Stock Units | 10,000 | $0.00 | $0.00 |
| Exercise | Performance-Based Restricted Stock Units | 5,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 2,302 | $0.00 | $0.00 |
| Exercise | Common Stock | 11,513 | $0.00 | $0.00 |
| Exercise | Common Stock | 5,756 | $0.00 | $0.00 |
| Sale | Common Stock | 19,310 | $602.11 | $11.63M |
| Exercise | Time-Based Restricted Stock Units | 3,333 | $0.00 | $0.00 |
| Exercise | Time-Based Restricted Stock Units | 1,333 | $0.00 | $0.00 |
| Exercise | Common Stock | 1,869 | $0.00 | $0.00 |
| Exercise | Common Stock | 736 | $0.00 | $0.00 |
Holdings After Transaction:
Time-Based Restricted Stock Units — 6,252 contracts (Direct);
Earnings Per Share Performance-Based Restricted Stock Units — 18,839 contracts (Direct);
Performance-Based Restricted Stock Units — 7,284 contracts (Direct);
Common Stock — 49,998 shares (Direct)
Footnotes (6)
- F1. Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Units ("TRSUs") awarded to the Reporting Person on April 16, 2024, 3,333 shares of Common Stock became issuable to the Reporting Person on April 16, 2026 and is adjusted for dividends.
- F2. Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on April 16, 2025, 1,333 shares of Common Stock became issuable to the Reporting Person on April 16, 2026 and is adjusted for dividends.
- F3. Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on April 17, 2023, 4,000 shares of Common Stock became issuable to the Reporting Person on April 17, 2026 and is adjusted for dividends.
- F4. Pursuant to three-year performance period vesting schedule of the Earnings Per Share Performance-Based Restricted Stock Units ("ERSUs") awarded to the Reporting Person on April 17, 2023, 20,000 shares of the Issuer's Common stock became issuable to the Reporting Person on April 17, 2026 and is adjusted for dividends. The target number of shares was 10,000.
- F5. Pursuant to three-year performance period vesting schedule of the Performance-Based Restricted Stock Units ("PRSUs") awarded to the Reporting Person on April 17, 2023, 10,000 shares of the Issuer's Common stock became issuable to the Reporting Person on April 17, 2026 and is adjusted for dividends. The target number of shares was 5,000.
- F6. On April 17, 2026, the Reporting Person sold 19,310 shares of the Issuer's common stock on the open market at an average price of $602.11 per share.
Key Figures
Shares sold: 19,310 shares
Average sale price: $602.11/share
Shares held after sale: 49,998 shares
+5 more
8 metrics
Shares sold
19,310 shares
Open-market sale on April 17, 2026
Average sale price
$602.11/share
Open-market sale of 19,310 shares
Shares held after sale
49,998 shares
Direct common stock holdings post-transaction
EPS-based RSUs vested
20,000 shares
Earnings per share performance-based RSUs, vs 10,000 target
Performance RSUs vested
10,000 shares
Performance-based RSUs, vs 5,000 target
TRSUs vested (2023 grant)
4,000 shares
Time-based RSUs became issuable on April 17, 2026
TRSUs vested (2024 grant)
3,333 shares
Time-based RSUs became issuable on April 16, 2026
TRSUs vested (2025 grant)
1,333 shares
Time-based RSUs became issuable on April 16, 2026
Key Terms
Time-Based Restricted Stock Units, Performance-Based Restricted Stock Units, Earnings Per Share Performance-Based Restricted Stock Units, open market, +1 more
5 terms
Time-Based Restricted Stock Units financial
"Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Units ("TRSUs") awarded..."
Time-based restricted stock units are a form of employee compensation where individuals are granted company shares that are earned over a set period, often as a reward for staying with the company. These shares typically become fully owned and transferable only after passing specific time milestones, encouraging long-term commitment. For investors, they highlight a company's focus on employee retention and can influence future stock supply and company stability.
Performance-Based Restricted Stock Units financial
"Pursuant to three-year performance period vesting schedule of the Performance-Based Restricted Stock Units ("PRSUs") awarded..."
Performance-based restricted stock units are a type of employee equity award that converts into company shares only if predefined financial or operational targets are met over a set period. Think of it like a bonus check that becomes stock only when specific goals are hit; it ties pay to results, aligning managers’ incentives with shareholders. Investors care because these awards affect future share count, executive incentives, and signal how management’s success will be measured and rewarded.
open market financial
"the Reporting Person sold 19,310 shares of the Issuer's common stock on the open market..."
An open market is a system where buying and selling of goods, services, or financial assets happen freely without restrictions or special controls. For investors, it means they can trade assets easily and quickly, which helps determine fair prices based on supply and demand. This environment encourages transparency and competition, making it easier to buy or sell with confidence.
vesting schedule financial
"Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Units..."
A vesting schedule is a timeline that determines when someone gains full ownership of certain benefits, such as company stock or retirement contributions. Think of it like earning the right to own a gift gradually over time, rather than receiving it all at once. It matters to investors because it affects when they can fully access or sell these benefits, influencing their financial planning and decision-making.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did AGX CEO David Hibbert Watson report?
David Hibbert Watson reported a sale of 19,310 Argan (AGX) common shares and multiple RSU vestings. The filing shows both time-based and performance-based awards converting into common stock alongside the open-market sale.
What performance-based RSUs vested for the Argan (AGX) CEO?
Performance-based RSUs tied to earnings per share and other metrics vested for the CEO. Footnotes state 20,000 shares became issuable from EPS-based units versus a 10,000-share target, and 10,000 shares from performance RSUs versus a 5,000-share target.
Did Argan (AGX) CEO Watson have time-based RSUs vest in this Form 4?
Yes. Time-based restricted stock units granted in 2023, 2024, and 2025 partially vested. Footnotes note issuable common stock of 4,000, 3,333, and 1,333 shares respectively on April 16–17, 2026, each adjusted for dividends per the award terms.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates